Pulmonary Embolism

Clinical Trial Finder

Many patients with pulmonary embolism are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Comparison of Three Scores for Ultrasound Assessment and Monitoring of Pulmonary Aeration

Conditions:   Atelectasis;   Pneumonia;   Acute Respiratory Distress Syndrome;   Pulmonary Embolism;   Hypoxemia;   Dyspnea
Interventions:   Procedure: Lung ultrasound examination on Day 1 and Day 2 to 4;   Procedure: Lung ultrasound examination on Day 1;   Device: GE Vivid Ultrasound system
Sponsor:   Centre hospitalier de l'Université de Montréal (CHUM)
Not yet recruiting - verified May 2015

Lung Ultrasound Safety in Humans

Condition:   Pulmonary Hemorrhage
Intervention:   Device: Observation for safety
Sponsor:   Massachusetts General Hospital
Not yet recruiting - verified May 2015

Comparison of Topical and Infusion Tranexamic Acid After Total Knee Arthroplasty

Condition:   Osteoarthritis, Knee
Interventions:   Drug: Tranexamic Acid 5%,5ml/amp;   Drug: Tranexamic Acid 5%,5ml/amp;   Drug: rivaroxaban (10mg);   Drug: 0.9% Normal Saline;   Drug: 0.9% Normal Saline
Sponsor:   Chang Gung Memorial Hospital
Not yet recruiting - verified May 2015

Early Post-Marketing Study of ELIQUIS (Apixaban) in Mexico

Conditions:   Deep Vein Thrombosis;   Pulmonary Embolism
Intervention:   Drug: Apixaban
Sponsor:   Bristol-Myers Squibb
Not yet recruiting - verified May 2015

Safety and Efficacy Study of Apixaban to Prevent Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With PEG Asparaginase

Conditions:   Lymphoma;   Acute Lymphoblastic Leukemia
Interventions:   Drug: Apixaban;   Other: No systemic anticoagulant prophylaxis
Sponsor:   Bristol-Myers Squibb
Recruiting - verified April 2015

Observational Study to Assess Sociodemographic and Clinical Features of Patients Treated With Rivaroxaban in Routine Clinical Practice of Hematologists, Cardiologists and Internists of Spain

Condition:   Atrial Fibrillation
Intervention:   Drug: Rivaroxaban (Xarelto, BAY59-7939)
Sponsor:   Bayer
Completed - verified May 2015

Pulmonary Embolism Diagnosis: Ultrasound Wells Score vs Traditional Wells Score

Condition:   Pulmonary Embolism
Intervention:  
Sponsor:   Azienda Ospedaliero-Universitaria Careggi
Recruiting - verified May 2015

PET CT in Suspected CIED Infection, a Pilot Study - PET Guidance I

Conditions:   Complications;   Infective Endocarditis;   Implant Site Pocket Infection;   Fever of Unknown Origin
Intervention:   Other: PET CT
Sponsor:   Institute of Cardiology, Warsaw, Poland
Recruiting - verified May 2015

Lung Ultrasound in Pleuritic Chest Pain

Conditions:   Community Acquired Pneumonia;   Pleuritis;   Pulmonary Embolism;   Lung Cancer
Intervention:   Procedure: Lung ultrasound
Sponsor:   University of Milan
Recruiting - verified May 2015

Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)

Conditions:   Pulmonary Embolism;   Thromboembolism;   Thrombosis;   Venous Thrombosis;   Venous Thromboembolism
Interventions:   Drug: BAY 59-7939;   Drug: BAY 59-7939;   Drug: ASA
Sponsor:   Bayer
Recruiting - verified May 2015

The SENTRY Clinical Study

Conditions:   Pulmonary Embolism;   Deep Vein Thrombosis
Intervention:   Device: SENTRY IVC Filter
Sponsor:   Novate Medical
Recruiting - verified May 2015

Venous Thromboembolic Prophylaxis After Major Trauma: A Trial of Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin

Conditions:   Venous Thromboembolic Disease;   Deep Vein Thrombosis;   Pulmonary Embolism
Interventions:   Drug: 5000 Units unfractionated Heparin Q 8 hours;   Drug: 30mg enoxaparin Q12 hours
Sponsor:   Scripps Health
Completed - verified May 2015

Age-adjusted D-dimer Cut-off Levels to Rule Out Pulmonary Embolism

Condition:   Pulmonary Embolism
Intervention:   Other: Evaluation of a modified DD cut-off to rule out PE
Sponsors:   Marc Righini;   University Hospital, Brest;   University Hospital, Angers;   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Completed - verified April 2013

Pulmonary Embolism Response to Fragmentation, Embolectomy, & Catheter Thrombolysis: PERFECT

Condition:   Pulmonary Embolism
Intervention:   Procedure: Catheter directed debulking of Pulmonary Embolus
Sponsors:   Stanford University;   Adventist Midwest Health;   Weill Medical College of Cornell University;   Maine Medical Center;   Memorial Hospital of South Bend;   Northside Hospital, Inc.;   Universidad de Zaragoza
Recruiting - verified May 2015

Obstructive Sleep Apnea and Venous Thromboembolism

Conditions:   Obstructive Sleep Apnea;   Venous Thrombosis;   Pulmonary Embolism;   Venous Thromboembolism
Intervention:  
Sponsor:   University of Missouri-Columbia
Withdrawn - verified May 2015

Point of Care Ultrasound (US) Versus Detailed Radiology US for Deep Vein Thrombosis (DVT)

Condition:   DEEP VEIN THROMBOSIS
Intervention:  
Sponsor:   University of Missouri-Columbia
Withdrawn - verified May 2015

Ruling Out Pulmonary Embolism During Pregnancy:a Multicenter Outcome Study

Conditions:   Pulmonary Embolism;   Deep Vein Thrombosis
Intervention:   Other: Pregnant patients with suspected PE will undergo a strategy based on clinical probability assessment, D-dimer, lower limb vein ultrasonography and MSCT.
Sponsors:   University Hospital, Geneva;   Swiss National Science Foundation
Recruiting - verified May 2015

Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure

Conditions:   Venous Thrombosis;   Pulmonary Embolism
Intervention:   Drug: Tinzaparin
Sponsors:   St. Joseph's Healthcare Hamilton;   Heart and Stroke Foundation of Ontario;   LEO Pharma
Recruiting - verified May 2015

Get CardioSmart

You're Invited